Evidence map›Paper›PMID 38144406›Full record

ArticleCanadian liver journal2022

Impacts of the COVID-19 pandemic on hepatitis C elimination in Canada: Where do we go from here?

Jawairia Atif, Sasha Tejna Persaud Udhesister, Mohamed N Abdelnabi, Simmone D'Souza, Jui-Hsia Hung, Rachel D Edgar, Samaa T Gobran, Elsa Gomez-Escobar, Zoë R Greenwald, Carla E Gallardo-Flores and 16 more

Abstract read
In one paragraph

Article in Canadian liver journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Hepatology in the time of COVID-19: Part 2.Canadian liver journal · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Jawairia AtifDepartment of Immunology, University of Toronto, Toronto, Ontario, Canada.
Sasha Tejna Persaud UdhesisterFaculté de Médecine, Université de Montréal, Centre de Recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.
Mohamed N AbdelnabiCentre de Recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Département de Microbiologie, Infectiologie et Immunologie, Faculté de Médecine, Université de Montréal, Montréal, Québec, Canada.
Simmone D'SouzaUniversity of Calgary Cumming School of Medicine, Calgary, Alberta, Canada.
Jui-Hsia HungSchool of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.
Rachel D EdgarUniversity of Toronto and European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.
Samaa T GobranFaculté de Médecine, Université de Montréal, Centre de Recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.
Elsa Gomez-EscobarCentre de Recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.
Zoë R GreenwaldDalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Carla E Gallardo-FloresDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada.
Guillaume FontaineClinical Epidemiology Program, Ottawa Research Institute Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Dahn JeongSchool of Population and Public Health, University of British Columbia, British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.
Charlotte Lanièce-DelaunayDepartment of Epidemiology, Biostatistics and Occupational Health, School of Population and Global Health, Faculty of Medicine, McGill University, Montréal, Québec, Canada.
David LawtonOttawa Hospital Research Institute Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Jean Damascene MakuzaSchool of Population and Public Health, University of British Columbia, British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.
Chelsea MastermanFaculty of Health Sciences, University of Western Ontario, London, Ontario, Canada.
Gayatri MaratheDepartment of Epidemiology, Biostatistics and Occupational Health, School of Population and Global Health, Faculty of Medicine, McGill University, Montréal, Québec, Canada.
Sameh MortazhejriSchool of Epidemiology and Public Health, University of Ottawa, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Jiafeng LiDepartment of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Michael PalmerDepartment of Biochemistry, Microbiology, and Immunology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Ana Maria Passos-CastilhoCentre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital; Department of Medicine, McGill University, Montréal, Québec, Canada.
Manolya SagDepartment of Biochemistry, McGill University, Montréal, Québec, Canada.
Mohamed ShengirDivision of Experimental Medicine, Department of Medicine, McGill University, Montréal, Québec, Canada.
Hannah Louise WallaceImmunology and Infectious Diseases, Division of Biomedical Sciences, Faculty of Medicine, Memorial University, St John's and Labrador, Newfoundland, Canada.
Andrew B MendlowitzToronto Centre for Liver Disease/Viral Hepatitis Care Network (VIRCAN), University Health Network, Toronto, Ontario, Canada.
2022–2023 trainees of the Canadian Network on Hepatitis C

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38144406
PMCPMC10735200

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.